Stock 531592 GENPHARMASEC LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Genpharmasec Limited

Equities

531592

INE861N01036

Market Closed - Bombay S.E.
Other stock markets
 06:00:57 2024-06-28 am EDT 		5-day change 1st Jan Change
2.06 INR +1.98% Intraday chart for Genpharmasec Limited +6.19% -55.89%
May. 24 Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
May. 24 Genpharmasec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Genpharmasec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Genpharmasec Limited Announces Appointment of Hardik Makwana as Company Secretary & Compliance Officer
CI
Genpharmasec Limited Announces Resignation of Heta Shah as Company Secretary / Compliance Officer
CI
Genpharmasec Limited Announces Resignation of Ulhas Narayan Deosthale from the Post of Executive Director
CI
Genpharmasec Limited completed the acquisition of an unknown stake in Derren Healthcare Private Limited from the existing shareholder.
CI
Genpharmasec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Genpharmasec Forms Subsidiary for Molecular Testing Services
MT
Genpharmasec Limited Forms New Wholly Owned Subsidiary Company Namely Clinigenome India Private Limited
CI
Genpharmasec Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Genpharmasec to Acquire 70% Stake in Derren Healthcare for INR126.4 Million
MT
Genpharmasec Limited signed a share purchase agreement to acquire an unknown stake in Derren Healthcare Private Limited from the existing shareholder for approximately INR 130 million.
CI
Genpharmasec Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Genpharmasec Sets Up Middle East Unit
MT
Genpharmasec Limited Incorporates Foreign Subsidiary Namely Genpharmasec Middle East DMCC
CI
Genpharmasec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Genpharmasec Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Genpharmasec Limited Announces Board Changes
CI
Genpharmasec Limited Announces CFO Changes
CI
Genpharmasec Limited Appoints Heta Shah as Company Secretary and Compliance Officer, with Effect from October 7, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 531592 Stock
  4. News Genpharmasec Limited